Arcturus Therapeutics Holdings (ARCT) Current Leases (2019 - 2026)

Arcturus Therapeutics Holdings has reported Current Leases for 8 years, with the latest figure at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 17.32% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 17.32% YoY), and the FY2025 full-year result was $4.2 million, up 18.64% from the prior year.
• Current Leases for Q1 2026 stood at $4.3 million, up from $4.2 million in the prior quarter.
• The five-year high for Current Leases was $4.3 million in Q4 2023, with the low at $1.7 million in Q1 2022.
• Historically, Current Leases has averaged $3.8 million across 5 years, with a median of $4.0 million in 2023.
• Annual changes were most pronounced in 2022 — Current Leases jumped 155.09% — and 2024, when it dropped 18.21%.
• Arcturus Therapeutics Holdings' Current Leases stood at $3.9 million in 2022, then grew by 10.94% to $4.3 million in 2023, then fell by 17.57% to $3.6 million in 2024, then grew by 18.64% to $4.2 million in 2025, then climbed by 2.21% to $4.3 million in 2026.
• The last three Current Leases figures came in at $4.3 million (Q1 2026), $4.2 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.